S‑Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope
Padam Singh,
Shashi Kant Kumar,
Vineet Kumar Maurya,
Basant Kumar Mehta,
Hafsa Ahmad,
Anil Kumar Dwivedi,
Vinita Chaturvedi,
Tejender S. Thakur,
Sudhir Sinha
Affiliations
Padam Singh
†Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow, India
Shashi Kant Kumar
†Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow, India
Vineet Kumar Maurya
†Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow, India
Basant Kumar Mehta
‡Division of Molecular and Structural Biology, CSIR-Central Drug Research Institute, Lucknow, India
Hafsa Ahmad
§Division of Pharmaceutics, CSIR-Central Drug Research Institute, Lucknow, India
Anil Kumar Dwivedi
§Division of Pharmaceutics, CSIR-Central Drug Research Institute, Lucknow, India
Vinita Chaturvedi
†Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow, India
Tejender S. Thakur
‡Division of Molecular and Structural Biology, CSIR-Central Drug Research Institute, Lucknow, India
Sudhir Sinha
†Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow, India
